In this context, it has been shown that overexpression of Smad3 suppresses cell apoptosis and promotes cell proliferation, whereas treatment with Smad3 inhibitor (SIS3) promotes apoptosis and inhibits proliferation of breast cancer cells.79 Here, SMAD3 is linked to breast carcinoma.